Stroke prevention in patients with hidden atrial fibrillation
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests if starting blood thinners can prevent another stroke in people who had a stroke but were found to have a hidden heart rhythm problem called atrial fibrillation. It is for older adults who have had a recent stroke without a known cause.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older and had a stroke within the last 15 days.
- Your stroke was confirmed by a brain scan (MRI or CT).
- Doctors did not find atrial fibrillation or a blood clot in your heart during your hospital stay.
- You have signs suggesting atrial fibrillation, such as strokes in different brain areas, a dilated heart chamber, or certain test results.
- You have agreed to wear a heart monitor (like a Holter or implantable loop recorder) for a long time to detect atrial fibrillation.
- Your disability level is mild to moderate (Rankin score 4 or less).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial studies whether it’s safer to avoid long-term blood thinners after a spontaneous brain bleed in people with atrial fibrillation (an irregular heart rhythm). It compares different prevention strategies to lower the risk of stroke or other blood-vessel problems without causing new, serious bleeding.
This trial tests whether taking apixaban alone is as safe and effective as taking apixaban plus clopidogrel for people who have had a stroke due to atrial fibrillation and also have hardened arteries in the brain or neck. It aims to find the best way to prevent another stroke.
This trial looks at ways to help people with atrial fibrillation lower their risk of stroke, premature death, and worsening memory. It may help by identifying which prevention approach works best for a broader community of patients.
This Phase 3 study tests whether a blood thinner (apixaban) can help prevent another stroke and support recovery after you’ve had a brain bleed. You would be assigned to a treatment group, and the study checks safety and whether strokes can be reduced without causing dangerous bleeding.
This trial is testing two blood thinners (edoxaban and apixaban) to see how they compare in preventing new brain spots on MRI after a stroke in people with atrial fibrillation. It may help you and your doctor choose the safer option.
This trial tests whether taking a blood thinner can lower the risk of stroke in people who had atrial fibrillation (an irregular heartbeat) that happened temporarily around a stressful illness or surgery. It looks especially at people at higher risk for stroke after that episode.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.